C. M. Blazey

Discovery of a novel class of highly potent, selective, ATP-competitive, and orally bioavailable inhibitors of the mammalian target of rapamycin (mTOR).

K. Yamaguchi, J. Nuss, J. Woolfrey, 2013, Journal of medicinal chemistry.

Regiochemistry in 1,3-dipolar cycloadditions of the azomethine ylide formed from diethyl aminomalonate and paraformaldehyde.

C. Heathcock, C. M. Blazey, 2002, The Journal of organic chemistry.

Alkyl side-chain derivatives of sordaricin as potent antifungal agents against yeast.

D. Schmatz, J. Balkovec, M. Hsu, 1998, Bioorganic & medicinal chemistry letters.

Pyrazolopyrimidines as dual Akt/p70S6K inhibitors.

Wei Xu, D. J. Matthews, J. Nuss, 2012, Bioorganic & Medicinal Chemistry Letters.

Novel Carboxamide-Based Allosteric MEK Inhibitors: Discovery and Optimization Efforts toward XL518 (GDC-0973).

J. Martini, J. Nuss, Joerg Bussenius, 2012, ACS medicinal chemistry letters.

Design and evaluation of a series of pyrazolopyrimidines as p70S6K inhibitors.

Wei Xu, D. J. Matthews, J. Nuss, 2012, Bioorganic & medicinal chemistry letters.

Discovery of XL888: a novel tropane-derived small molecule inhibitor of HSP90.

S. Malek, J. Martini, J. Nuss, 2012, Bioorganic & medicinal chemistry letters.

Application of a novel directing effect in an organocopper/orthoester reaction to the synthesis of deuterium labeled unsaturated esters

J. Meinwald, A. Svatoš, J. C. Shattuck, 1997 .